search
Back to results

Supernormal Oxygen Delivery for Elderly Surgical Patients (SNODES)

Primary Purpose

Femoral Fractures

Status
Unknown status
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
SV maximization
supernormal DO2
Sponsored by
Guangzhou First People's Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Femoral Fractures focused on measuring proximal femoral fracture, goal-directed therapy, myocardial injury, supernormal oxygen delivery, elders, stroke volume maximization

Eligibility Criteria

70 Years - undefined (Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Adult patients scheduled for proximal femur fracture (PFF) surgery at this institution
  2. American Society of Anaesthesiologists (ASA) physical status of III or VI
  3. Two or more risk factors according to risk index of Lee

Exclusion Criteria:

  1. Patient age < 70 yrs
  2. Ongoing myocardial infarct or ischemia
  3. Chronic haemodialysis
  4. Inability to cooperate in the study
  5. Patient refusal

Sites / Locations

  • Guangzhou First People's HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Placebo Comparator

Experimental

Arm Label

SV maximization

supernormal DO2

Arm Description

Goal-directed fluid therapy with stroke volume maximization. Device: The Volume-View system from Edwards Co.

Goal-directed fluid therapy with stroke volume maximization and supernormal oxygen delivery. Device: The Volume-View system from Edwards Co.

Outcomes

Primary Outcome Measures

Change from baseline in concentration of troponin T at 24 hours postoperatively
Intraoperative supernormal oxygen delivery strategy will reduce the changes in concentration of troponin T at 24 hours postoperatively.

Secondary Outcome Measures

cardiac complication up to 24 hours postoperatively
Occurrence of newly diagnosed arterial fibrilation ,severe arrhythmia,clinical signs of unstable angina, myocardial infarction,pulmonary edema or therapy-requiring cardiac failure.
blood pressure
Invasive arterial BP(mmHg) is measured through an arterial line at the arm.episode of hypotension (30% decrease in mean BP in relation to baseline values) and hypertension (30% increase in mean BP in relation to baseline values) will be recorded.
heart rate (HR)
HR(beats/min), bradycardia (HR < 50 beats/min), and tachycardia (HR > 100 beats/min) will be recorded at the same time as BP recording.
SpO2
SpO2(%) and hypoxemia (SpO2 <90%) will be recorded at the same time as BP recording.
fluid balance
amount of fluids (ml) infused, amount of fluid losses
blood transfusion volume
amount of blood transfusion, amount of blood losses.
Acute Kidney Injury
perioperative and 24h postoperative urine volume, serum creatinine, blood urea nitrogen.
Postoperative Nausea and Vomiting (PONV)
Postoperative Nausea and Vomiting, The incidence of PONV will be recorded using a 4-point objective score (1 = no PONV;2 = mild nausea, no vomiting; 3 = excessive nausea or vomiting;4 = vomiting ≥2 times).
length of postoperative hospital stay
days from end of surgery to hospital discharge
mortality
mortality within 28 days after surgery
cardiac complication at 28 days postoperatively
Occurrence of newly diagnosed arterial fibrilation ,severe arrhythmia,clinical signs of unstable angina, myocardial infarction,pulmonary edema or therapy-requiring cardiac failure.
incidence of pulmonary infection
number of patients having pulmonary infection requiring intravenous antibiotic therapy

Full Information

First Posted
December 9, 2015
Last Updated
February 14, 2017
Sponsor
Guangzhou First People's Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT02629250
Brief Title
Supernormal Oxygen Delivery for Elderly Surgical Patients
Acronym
SNODES
Official Title
A Randomized Controlled Study of Supernormal Oxygen Delivery Goal-directed Therapy for Elderly Patients Undergoing Proximal Femoral Surgery.
Study Type
Interventional

2. Study Status

Record Verification Date
February 2017
Overall Recruitment Status
Unknown status
Study Start Date
December 2015 (undefined)
Primary Completion Date
February 2017 (Anticipated)
Study Completion Date
March 2017 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Guangzhou First People's Hospital

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Elderly patients with poor cardiopulmonary reserve tend to suffer higher risk and develop more complications following major surgery. Quite a few researches have shown the benefits of goal-directed therapy (GDT) using fluid loading or inotropic agents or both to improve outcome during major surgery. However there is concern that inotropic therapy for a supernormal oxygen delivery (DO2I) may lead to an increased incidence of myocardial ischemia. Even though the meta-analysis has stated that DO2I strategy could possibly reduce the incidence of cardiac complication than stroke volume optimization strategy, there are very few evidence available in the literature regarding the effect on myocardial ischemia in surgical patients, especially in non-cardiac surgical patients. This study is undertaken to test the hypothesis that an intraoperative DO2I optimization result in a decreased myocardial ischemia in the elderly high-risk surgical patients.
Detailed Description
Elderly patients with poor cardiopulmonary reserve tend to suffer higher risk and develop more complications following major surgery [1]. Quite a few researches have shown the benefits of goal-directed therapy(GDT) using fluid loading or inotropic agents or both to improve outcome during major surgery [2-7]. The maintenance of adequate tissue perfusion and global oxygen delivery (DO2I) is essential to maintain adequate tissue perfusion and oxygenation in relation to increased metabolic demand during high risk surgery. However, there is concern that inotropic therapy for a supernormal oxygen delivery may lead to an increased incidence of myocardial ischemia [8]. Even though the meta-analysis has stated that DO2I optimization could possibly reduce the incidence of cardiac complication than stroke volume optimization strategy [9],there are very few evidence available in the literature regarding the effect on myocardial ischemia in surgical patients, especially in non-cardiac surgical patients. This study is undertaken to test the hypothesis that an intraoperative DO2I optimization result in a decreased myocardial ischemia in the elderly high-risk surgical patients. The investigators will conduct a prospective, randomized, controlled, double-blinded trial in seventy patients who scheduled for proximal femur surgery under General anesthesia following nerve block. Both the patients will be allocated to one of two equal groups to receive either intraoperative fluid regimen guided by SV strategy or DO2I strategy. In the control(SV) group, the patients will receive an intravenous infusion of 250 ml Ringer's lactate solution in 5 min as a fluid challenge for stroke volume maximization. In the experimental(DO2I) group, fluid and dobutamine will be given to reach a stroke volume maximization and supernormal oxygen delivery. The primary outcome is preoperative and 24h postoperative serum concentration of troponin T. Secondary outcomes include the incidence of tachycardia, arrhythmia, myocardial infarction, pneumonedema and acute heart failure, blood pressure, pulmonary infection, fluid volume, blood transfusion volume, renal function, PONV, Length of postoperative hospital stay and mortality. Data will be collected and recorded by the clinical teams who are blind to study arm allocation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Femoral Fractures
Keywords
proximal femoral fracture, goal-directed therapy, myocardial injury, supernormal oxygen delivery, elders, stroke volume maximization

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderOutcomes Assessor
Allocation
Randomized
Enrollment
70 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
SV maximization
Arm Type
Placebo Comparator
Arm Description
Goal-directed fluid therapy with stroke volume maximization. Device: The Volume-View system from Edwards Co.
Arm Title
supernormal DO2
Arm Type
Experimental
Arm Description
Goal-directed fluid therapy with stroke volume maximization and supernormal oxygen delivery. Device: The Volume-View system from Edwards Co.
Intervention Type
Procedure
Intervention Name(s)
SV maximization
Other Intervention Name(s)
Stroke volume maximization
Intervention Description
When SpO2 ≥92%, mean arterial pressure (MAP) 65-100 mmHg, HR <100 bpm, Hb >8mg/dL and temperature ≥36℃, the patients will receive a 250 ml Ringer's lactate solution in 5 min as a fluid challenge for stroke volume (SV) maximization. The fluid challenge will repeat until the SV failed to increase by a factor of 10%. A reassessment on the SV maximization will be taken every 30 minutes and to restart algorithm when increased SV >10% or blood loss >250ml. Blood transfusions will be used to maintain a hemoglobin concentration over 8mg/dL.
Intervention Type
Procedure
Intervention Name(s)
supernormal DO2
Other Intervention Name(s)
Stroke volume maximization + supernormal oxygen delivery
Intervention Description
Goal directed fluid therapy is administrated as group SV maximization. Then DO2I will be assessed. If at this stage the DO2I can not be greater than 600 mL/m2 (supernormal oxygen delivery goal), then dobutamine will be started at a dose of 2.5 μg/kg/min and increased by the same increment every 20 minutes until the described target is reached or until a maximal dose of 20 μg/kg/min is given. Dobutamine is decreased in dose or discontinued if the heart rate is above 100 beats per minute or shows signs of cardiac ischemia.
Primary Outcome Measure Information:
Title
Change from baseline in concentration of troponin T at 24 hours postoperatively
Description
Intraoperative supernormal oxygen delivery strategy will reduce the changes in concentration of troponin T at 24 hours postoperatively.
Time Frame
preoperative value and 24 hours postoperatively
Secondary Outcome Measure Information:
Title
cardiac complication up to 24 hours postoperatively
Description
Occurrence of newly diagnosed arterial fibrilation ,severe arrhythmia,clinical signs of unstable angina, myocardial infarction,pulmonary edema or therapy-requiring cardiac failure.
Time Frame
up to 24 hours postoperatively
Title
blood pressure
Description
Invasive arterial BP(mmHg) is measured through an arterial line at the arm.episode of hypotension (30% decrease in mean BP in relation to baseline values) and hypertension (30% increase in mean BP in relation to baseline values) will be recorded.
Time Frame
up to 24 hours postoperatively
Title
heart rate (HR)
Description
HR(beats/min), bradycardia (HR < 50 beats/min), and tachycardia (HR > 100 beats/min) will be recorded at the same time as BP recording.
Time Frame
up to 24 hours postoperatively
Title
SpO2
Description
SpO2(%) and hypoxemia (SpO2 <90%) will be recorded at the same time as BP recording.
Time Frame
up to 24 hours postoperatively
Title
fluid balance
Description
amount of fluids (ml) infused, amount of fluid losses
Time Frame
up to 24hours after surgery
Title
blood transfusion volume
Description
amount of blood transfusion, amount of blood losses.
Time Frame
up to 24 hours postoperatively
Title
Acute Kidney Injury
Description
perioperative and 24h postoperative urine volume, serum creatinine, blood urea nitrogen.
Time Frame
up to 24 hours postoperatively
Title
Postoperative Nausea and Vomiting (PONV)
Description
Postoperative Nausea and Vomiting, The incidence of PONV will be recorded using a 4-point objective score (1 = no PONV;2 = mild nausea, no vomiting; 3 = excessive nausea or vomiting;4 = vomiting ≥2 times).
Time Frame
24 hours postoperatively
Title
length of postoperative hospital stay
Description
days from end of surgery to hospital discharge
Time Frame
28 days postoperatively
Title
mortality
Description
mortality within 28 days after surgery
Time Frame
28 days postoperatively
Title
cardiac complication at 28 days postoperatively
Description
Occurrence of newly diagnosed arterial fibrilation ,severe arrhythmia,clinical signs of unstable angina, myocardial infarction,pulmonary edema or therapy-requiring cardiac failure.
Time Frame
28 days postoperatively
Title
incidence of pulmonary infection
Description
number of patients having pulmonary infection requiring intravenous antibiotic therapy
Time Frame
up to 28 days postoperatively
Other Pre-specified Outcome Measures:
Title
Postoperative pain
Description
Postoperative pain using visual analog scale (VAS, 0-100, 0 = no pain, 100 = maximum imaginable pain) will be assessed.
Time Frame
24 hours postoperatively

10. Eligibility

Sex
All
Minimum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adult patients scheduled for proximal femur fracture (PFF) surgery at this institution American Society of Anaesthesiologists (ASA) physical status of III or VI Two or more risk factors according to risk index of Lee Exclusion Criteria: Patient age < 70 yrs Ongoing myocardial infarct or ischemia Chronic haemodialysis Inability to cooperate in the study Patient refusal
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Xiangcai Ruan, MD, PhD
Phone
+8620-81048306
Email
xc_ruan@hotmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Jingjing Tang
Phone
+8618898533061
Email
15059038216@163.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Xiangcai Ruan, MD, PhD
Organizational Affiliation
Guangzhou First People's Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Guangzhou First People's Hospital
City
Guangzhou
State/Province
Guangdong
ZIP/Postal Code
510180
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Xiangcai Ruan, MD, PHD
Phone
86-20-81048306
Email
xc_ruan@hotmail.com
First Name & Middle Initial & Last Name & Degree
Xiangcai Ruan, MD, PHD
First Name & Middle Initial & Last Name & Degree
Bin Zheng, MD, Msc
First Name & Middle Initial & Last Name & Degree
Jingjing Tang, MD
First Name & Middle Initial & Last Name & Degree
Wei Liu, MD
First Name & Middle Initial & Last Name & Degree
Chengxiang Lu, MD, Msc

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
7104132
Citation
Fowkes FG, Lunn JN, Farrow SC, Robertson IB, Samuel P. Epidemiology in anaesthesia. III: Mortality risk in patients with coexisting physical disease. Br J Anaesth. 1982 Aug;54(8):819-25. doi: 10.1093/bja/54.8.819.
Results Reference
background
PubMed Identifier
20966436
Citation
Hamilton MA, Cecconi M, Rhodes A. A systematic review and meta-analysis on the use of preemptive hemodynamic intervention to improve postoperative outcomes in moderate and high-risk surgical patients. Anesth Analg. 2011 Jun;112(6):1392-402. doi: 10.1213/ANE.0b013e3181eeaae5. Epub 2010 Oct 21.
Results Reference
background
PubMed Identifier
17822565
Citation
Lopes MR, Oliveira MA, Pereira VO, Lemos IP, Auler JO Jr, Michard F. Goal-directed fluid management based on pulse pressure variation monitoring during high-risk surgery: a pilot randomized controlled trial. Crit Care. 2007;11(5):R100. doi: 10.1186/cc6117.
Results Reference
background
PubMed Identifier
16696864
Citation
Lobo SM, Lobo FR, Polachini CA, Patini DS, Yamamoto AE, de Oliveira NE, Serrano P, Sanches HS, Spegiorin MA, Queiroz MM, Christiano AC Jr, Savieiro EF, Alvarez PA, Teixeira SP, Cunrath GS. Prospective, randomized trial comparing fluids and dobutamine optimization of oxygen delivery in high-risk surgical patients [ISRCTN42445141]. Crit Care. 2006;10(3):R72. doi: 10.1186/cc4913. Epub 2006 May 12.
Results Reference
background
PubMed Identifier
17925428
Citation
Donati A, Loggi S, Preiser JC, Orsetti G, Munch C, Gabbanelli V, Pelaia P, Pietropaoli P. Goal-directed intraoperative therapy reduces morbidity and length of hospital stay in high-risk surgical patients. Chest. 2007 Dec;132(6):1817-24. doi: 10.1378/chest.07-0621. Epub 2007 Oct 9.
Results Reference
background
PubMed Identifier
10213716
Citation
Wilson J, Woods I, Fawcett J, Whall R, Dibb W, Morris C, McManus E. Reducing the risk of major elective surgery: randomised controlled trial of preoperative optimisation of oxygen delivery. BMJ. 1999 Apr 24;318(7191):1099-103. doi: 10.1136/bmj.318.7191.1099.
Results Reference
background
PubMed Identifier
16356219
Citation
Pearse R, Dawson D, Fawcett J, Rhodes A, Grounds RM, Bennett ED. Early goal-directed therapy after major surgery reduces complications and duration of hospital stay. A randomised, controlled trial [ISRCTN38797445]. Crit Care. 2005;9(6):R687-93. doi: 10.1186/cc3887. Epub 2005 Nov 8.
Results Reference
background
PubMed Identifier
17371601
Citation
Pearse RM, Dawson D, Fawcett J, Rhodes A, Grounds RM, Bennett D. The incidence of myocardial injury following post-operative Goal Directed Therapy. BMC Cardiovasc Disord. 2007 Mar 19;7:10. doi: 10.1186/1471-2261-7-10.
Results Reference
background
PubMed Identifier
20920151
Citation
Futier E, Vallet B. Inotropes in goal-directed therapy: do we need 'goals'? Crit Care. 2010;14(5):1001. doi: 10.1186/cc9251. Epub 2010 Sep 29.
Results Reference
background

Learn more about this trial

Supernormal Oxygen Delivery for Elderly Surgical Patients

We'll reach out to this number within 24 hrs